Murine Langerin + dermal dendritic cells prime CD 8 + T cells while L angerhans cells induce cross‐tolerance-Reference-Cited by-同舟云学术

Murine Langerin + dermal dendritic cells prime CD 8 + T cells while L angerhans cells induce cross‐tolerance

Published:2014-08 Issue:9 Volume:6 Page:1191-1204
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Flacher Vincent¹²,Tripp Christoph H¹²,Mairhofer David G¹,Steinman Ralph M³,Stoitzner Patrizia¹,Idoyaga Juliana³,Romani Nikolaus¹²

Affiliation:

1. Department of Dermatology and Venereology Innsbruck Medical University Innsbruck Austria

2. Oncotyrol Center for Personalized Cancer Medicine Innsbruck Austria

3. Laboratory of Cellular Physiology and Immunology and Chris Browne Center for Immunology and Immune Diseases The Rockefeller University New York NY USA

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201303283

Reference83 articles.

1. Cutting Edge: Virus Selectively Primes Human Langerhans Cells for CD70 Expression Promoting CD8+ T Cell Responses

2. Steady state migratory RelB+ langerin+ dermal dendritic cells mediate peripheral induction of antigen-specific CD4+CD25+Foxp3+ regulatory T cells

3. Cross-presentation of viral and self antigens by skin-derived CD103+ dendritic cells

4. Effector and memory CD8+ T cell differentiation: toward a molecular understanding of fate determination

5. Toll-dependent selection of microbial antigens for presentation by dendritic cells

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epithelial dendritic cells vs. Langerhans cells: Implications for mucosal vaccines;Cell Reports;2024-04

2. Transdermally delivered tolerogenic nanoparticles induced effective immune tolerance for asthma treatment;Journal of Controlled Release;2024-02

3. Protection against tuberculosis achieved by dissolving microneedle patches loaded with live Mycobacterium paragordonae in a BCG prime-boost strategy;Frontiers in Immunology;2023-06-16

4. Cross-presentation by the others;Seminars in Immunology;2023-05

5. Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis;Journal of Neuroinflammation;2022-12-12